Buy or sell Laronde stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Laronde Stock

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

About Laronde Stock

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Funding History

May 2021$50.0M
August 2021$440M

Management

Co-founder and Chairman of the Board

Noubar Afeyan

Co-founder & Board of Directors

Avak Kahvejian

Board of Directors

Noubar Afeyan

Chief Operating Officer

Tej Pavoor

Chief Technology Officer

Vadim Dudkin

Head of Manufacturing

Tushar Misra

CEO

Diego Miralles

Chief Scientific Officer

Jesper Gromada

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo